Hedge Fund - Euclidean Capital
Foghorn Therapeutics Inc. (FHTX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q2 (2025-06-30) | $7,396,677 | 2.42% | 1,573,761 | $4.18 |
| 2 | 2025 - Q1 (2025-03-31) | $5,744,228 | 2.16% | 1,573,761 | $4.56 |
| 3 | 2024 - Q4 (2024-12-31) | $7,428,152 | 1% | 1,573,761 | $7.28 |
| 4 | 2024 - Q3 (2024-09-30) | $14,651,715 | 1.61% | 1,573,761 | $7.24 |
| 5 | 2024 - Q2 (2024-06-30) | $9,049,126 | 1.13% | 1,573,761 | $5.96 |
| 6 | 2024 - Q1 (2024-03-31) | $10,559,936 | 1.35% | 1,573,761 | $5.55 |
| 7 | 2023 - Q4 (2023-12-31) | $10,150,758 | 1.14% | 1,573,761 | $4.31 |
| 8 | 2023 - Q3 (2023-09-30) | $7,868,805 | 1.71% | 1,573,761 | $7.71 |
| 9 | 2023 - Q2 (2023-06-30) | $11,079,277 | 2.84% | 1,573,761 | $6.99 |
| 10 | 2023 - Q1 (2023-03-31) | $7,819,818 | 6.86% | 1,261,261 | $6.55 |
| 11 | 2022 - Q4 (2022-12-31) | $8,046,845 | 7.52% | 1,261,261 | $7.54 |
| 12 | 2022 - Q3 (2022-09-30) | $10,822,000 | 10.04% | 1,261,261 | $12.87 |
| 13 | 2022 - Q2 (2022-06-30) | $17,153,000 | 14.58% | 1,261,261 | $12.91 |
| 14 | 2022 - Q1 (2022-03-31) | $19,209,000 | 11.16% | 1,261,261 | $13.72 |
| 15 | 2021 - Q4 (2021-12-31) | $28,845,000 | 16.39% | 1,261,261 | $14.37 |
| 16 | 2021 - Q3 (2021-09-30) | $17,569,000 | 8.53% | 1,261,261 | $11.07 |
| 17 | 2021 - Q2 (2021-06-30) | $13,458,000 | 4.36% | 1,261,261 | $10.90 |
| 18 | 2021 - Q1 (2021-03-31) | $16,623,000 | 5.56% | 1,261,261 | $16.39 |
| 19 | 2020 - Q4 (2020-12-31) | $25,566,000 | 5.41% | 1,261,261 | $19.16 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center